Cargando…

Plasma neuronal exosomal levels of Alzheimer's disease biomarkers in normal aging

Plasma neuronal exosomal levels of pathogenic Alzheimer's disease (AD) proteins, cellular survival factors, and lysosomal proteins distinguish AD patients from control subjects, but changes in these exosomal proteins associated with normal aging have not been described for cognitively intact su...

Descripción completa

Detalles Bibliográficos
Autores principales: Abner, Erin L., Jicha, Gregory A., Shaw, Leslie M., Trojanowski, John Q., Goetzl, Edward J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863753/
https://www.ncbi.nlm.nih.gov/pubmed/27231710
http://dx.doi.org/10.1002/acn3.309
Descripción
Sumario:Plasma neuronal exosomal levels of pathogenic Alzheimer's disease (AD) proteins, cellular survival factors, and lysosomal proteins distinguish AD patients from control subjects, but changes in these exosomal proteins associated with normal aging have not been described for cognitively intact subjects. Plasma neuronal exosomal levels of P‐T181‐tau, P‐S396‐tau, Aβ (1‐42), cathepsin D, repressor element 1‐silencing transcription factor, and neurogranin were quantified longitudinally in cognitively intact older adults using two samples collected at 3‐ to 11‐year intervals. Except for P‐S396‐tau, exosomal protein levels changed significantly with aging, but were largely outside the range observed in AD patients.